Background
Dialysis patients are frequently exposed to
Staphylococcus aureus
due to stays in dialysis centers, hospitals or rest homes. The hemodialysis vascular access is a potential entry site for
S. aureus
, in particular when using a central venous catheter (CVC) which increases the risk of sepsis compared to arteriovenous (AV) fistula. We prospectively followed a cohort of 86 hemodialysis patients from an outpatient dialysis center over 25 months analyzing
S. aureus
carrier status,
S. aureus
infection rates and mortality.
Methods
Demographic data and patients´ medical histories were collected and followed from all hemodialysis patients. Blood samples, nasal swabs and swabs from the hemodialysis vascular access site were taken every six months for a period of 25 months and tested for
S. aureus
. Strains were cultured and further characterized by
spa
PCR and microarray-based genotyping. Resulting data were compared with those from the general population.
Results
In cross-sectional analyses, an average of 40% of hemodialysis patients were
S. aureus
carriers compared to 27% in the general population. Longitudinally, a total of 65% were
S. aureus
carriers: 16% were persistent carriers, 43% were intermittently colonized. The most common
S. aureus
lineage in the dialysis patient cohort was the clonal complex (CC) 8 and the
spa
type t008, while in the general population, the clonal complex CC30 dominates. During the study period, we observed six
S. aureus
-associated blood stream infections with one
S. aureus
attributable death.
S. aureus
carriers with an AV fistula were more densely colonized in the nasal mucosa compared to patients with a CVC. Overall mortality was lower for hemodialysis patients with a positive
S. aureus
carrier status compared to non-carriers (hazard ratio of 0.19).
Conclusions
Compared to the general population, hemodialysis patients were more frequently colonized with
S. aureus
and displayed both different
S. aureus
colonization densities as well as lineages, possibly explained by more frequent exposure to health care environments. The lower overall mortality in carriers compared to non-carriers is intriguing and will be investigated in detail in the future.
Trial registration
ISRCTN 14385893
, 2. October 2018, retrospectively registered.
Electronic supplementary material
The online version of this article (10.1186/s12882-019-1332-z) contains supplementary material, which is available to authorize...